Global Nucleic Acid Testing Market to Reach US$5.6 Billion by 2015, According to New Report by Global Industry Analysts, Inc.

Share Article

GIA announces the release of a comprehensive global report on nucleic acid testing market. Global market for nucleic acid testing is projected to reach US$5.6 billion by the year 2015. Growing demand for nucleic acid testing in developing customized medicines and in enhancing the healthcare sector within the life sciences industry is expected to accelerate the market in the coming years.

Nucleic Acid Testing: A Global Market Report

Nucleic acid testing (NAT) is one of the fastest-growing segments of the molecular diagnostics market. Nucleic acid tests outweigh the traditional culture techniques in terms of sensitivity and speed. NAT based tools are widely being used for developing in-vitro diagnostics (IVD) and for discovery and manufacture of novel biomarkers. NAT is the most advanced diagnostic test for examining pathogens of interest and other various genetic disorders. Despite NAT being in the developing stages, the tests are one of the fastest growing segments of the IVD industry. The segment is mainly driven by Viral load applications, HIV, hepatitis and CMV diagnostics.

The US represents the world’s largest market for nucleic acid testing as stated by the new market research report on Nucleic Acid Testing. Adoption of the nucleic acid testing by the clinical laboratory field has been at a rather slow pace than estimated. However, the adoption rate of molecular diagnostics is most likely to increase in the coming years, thanks to the advent of various new technologies such as blotting technologies, amplification technologies, microarray, RNA inhibition analysis, probe technologies, electrophoretic technologies and others.

Major players in nucleic acid testing profiled in the report include Abbott Laboratories Inc., Applied Biosystems Group, Becton, Dickinson and Company, Genomic Health Inc., Genzyme Corporation, Myriad Genetic Inc., Novartis AG, Roche Diagnostics and Siemens Healthcare Diagnostics Inc., among others.

The report titled “Nucleic Acid Testing: A Global Market Report” announced by Global Industry Analysts, Inc., provides overview of market, market trends, product overview, product developments/introductions, and recent industry activity. The study analyzes market data and analytics in terms of value for regions including the US, and Rest of World. Further, the report analyzes European Nucleic Acid-based Amplification Reagents market by the following segments - Genetic Testing, Infectious Diseases, and Transplant Diagnostics.

For more details about this comprehensive market research report, please visit – http://www.strategyr.com/Nucleic_Acid_Testing_Market_Report.asp

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world’s largest market research publishers. The company employs over 800 people worldwide and publishes more than 1100 full-scale research reports each year. Additionally, the company also offers thousands of smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.
Telephone 408-528-9966
Fax 408-528-9977
Email press(at)StrategyR(dot)com
Web Site http://www.StrategyR.com/

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Public Relations
Visit website

Media